Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000033

Chief Executive Officer sold 1,729 shares at $41.30 ($71,408)

From the SEC's structured data for this filing

Trades in this filing

Klein Lawrence Otto · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Sale : show line 1 in the form −1,729 $41.30 $71,408 927,309 D
Open-market sales · 1,729 sh · avg $41.30 · $71,408
Loading xslF345X05/form4.xml…